Luc Perrin1. Show Affiliations » 1. Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland. luc.perrin@hcuge.ch
Abstract
Entities: Disease
Mesh： See more » AIDS Vaccines/geneticsAIDS Vaccines/therapeutic useAnti-HIV Agents/therapeutic useAntiretroviral Therapy, Highly ActiveCD8-Positive T-Lymphocytes/immunologyCD8-Positive T-Lymphocytes/pathologyCarbamatesCombined Modality TherapyDefective Viruses/geneticsDefective Viruses/immunologyDideoxynucleosides/therapeutic useHIV Infections/drug therapyHIV Infections/immunologyHIV Infections/pathologyHIV Infections/therapyHumansImmunotherapy, ActiveLamivudine/therapeutic useLymphocyte CountSulfonamides/therapeutic useT-Lymphocyte Subsets/immunologyVaccinationVaccinia virus/geneticsVaccinia virus/immunologyViral LoadViral Vaccines/immunologyViremia/drug therapyViremia/immunologyViremia/pathologyViremia/therapyZidovudine/therapeutic use
Substances： See more » AIDS VaccinesALVAC-HIV vCP1452Anti-HIV AgentsCarbamatesDideoxynucleosidesSulfonamidesViral VaccinesremuneLamivudineZidovudineamprenavirabacavir
Year: 2002 PMID： 11983263 DOI： 10.1016/s0264-410x(02)00087-7
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641